Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-08-001205
Filing Date
2008-03-25
Accepted
2008-03-25 15:34:39
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K w51675e10vk.htm 10-K 1330939
2 EX-23.1 w51675exv23w1.htm EX-23.1 1452
3 EX-31.1 w51675exv31w1.htm EX-31.1 8567
4 EX-31.2 w51675exv31w2.htm EX-31.2 8798
5 EX-32.1 w51675exv32w1.htm EX-32.1 3260
6 EX-32.2 w51675exv32w2.htm EX-32.2 3155
7 GRAPHIC w51675w5167501.gif GRAPHIC 10058
8 GRAPHIC w51675w5167502.gif GRAPHIC 18407
  Complete submission text file 0000950133-08-001205.txt   1397187
Mailing Address 20425 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600
MiddleBrook Pharmaceuticals, Inc. (Filer) CIK: 0001161924 (see all company filings)

EIN.: 522208264 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50414 | Film No.: 08709334
SIC: 2834 Pharmaceutical Preparations